We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Welcome to PracticeUpdate! We hope you are enjoying access to a selection of our top-read and most recent articles. Please register today for a free account and gain full access to all of our expert-selected content.
You can find your saved items on your dashboard, in the "saved" tab.
You've recommended your first item
Your recommendations help us improve our content suggestions for you and other PracticeUpdate members.
You've subscribed to your first topic alert
What does that mean?
Each day, we'll check to see if new items have been published to the topics you're subscribed to, and we'll send you one email with all of the new items from that day.
We'll keep all topic alert notifications available on your dashboard for 30 days, to make sure you don't miss anything.
Lastly, whenever you have unread items in the topics you've subscribed to, the "Alerts" icon will light up in the main menu. Just click on the bell to see your five most-recent, unread notifications.
This study evaluated patients with a prior history of diabetes who were admitted to any of 68 French hospitals between March 10, 2020, and April 10, 2020. The primary endpoint was a composite of tracheal intubation or death by day 7 of hospitalization. Of 2608 patients, 58 (2.2%) carried a diagnosis of type 1 diabetes (T1D). This compares with a prevalence of 5.6% of T1D in the general French population. The primary outcome was met by 23.2% of patients with T1D compared with 27.7% of those with type 2 diabetes (T2D). Among patients younger than 55 years of age, the primary outcome was met by 12.0% of patients with T1D versus 30.5% of patients with T2D. Among those 75 years of age and older, the primary outcome was met by 50.0% of those with T1D versus 25.9% of those with T2D.
Among patients with diabetes hospitalized for COVID-19, the risk of severe prognosis appears to be lower in those with T1D versus those with T2D, particularly in younger patients. The severity of COVID-19 in patients with T1D appears primarily to be due to age; the previously described association of hypertension with severe COVID-19 appears to be driven partly by age.
This abstract is available on the publisher's site.
Since the start of the coronavirus disease 2019 (COVID-19) pandemic, patients with diabetes were rapidly recognized as a high-risk population for severe disease. Indeed, a high prevalence of diabetes among patients with COVID-19 who required hospitalization has been consistently reported, reaching 33.8% in 5,700 people hospitalized for COVID-19 in the New York City area (1). In addition, diabetes was associated with more than a doubled risk of intensive care unit (ICU) admission and more than a tripled risk of death (2). However, precise data regarding the type of diabetes are scarce. We report here the clinical characteristics and early prognosis of patients with type 1 diabetes (T1D) hospitalized for COVID-19 in the nationwide multicentre observational CORONADO (Coronavirus SARS-CoV-2 and Diabetes Outcomes) study (3).